The mechanism underlying the relationship between obesity-linked CRC risk is that obesity promotes insulin resistance or hyperinsulinemia, chronic inflammation, oxidative stress, DNA damage, and elevated insulin-like growth factor-1 (IGF-1) levels, stimulating cell proliferation [47]. The gene discussed is IGF1; the disease is Insulin resistance.